Review: Urgent After-Hours Primary Care Services Funded through the MBS
Published: 2017 National
HCCA would like to emphasise that consumers do not choose and attribute the Medicare item number to a service. However, consumers’ needs and preferences should be considered in making any changes to the system. Without sufficiently understanding consumer need for health care after-hours, it is difficult to say whether restricting…Senate Inquiry into Chronic Disease
Published: 2015 National
HCCA made this submission to the Senate's Standing Committee on Health on Chronic Disease Prevention and Management in Primary Health Care. HCCA sees an enhanced focus on primary health care within the community as cost effective and a way to reduce spending in tertiary care. Primary health care, health promotion…Financial & Tax Practices of For-Profit Aged Care Providers
Published: 2018 National
As a result of takeover activity during the past decade, a small number of major private providers are now responsible for the accommodation of tens of thousands of aged care residents, and the stewardship of billions of dollars of refundable accommodation payments.Commonwealth Department of Health: Options to Reduce Pressure on Private Health Insurance Premiums Paper
Published: 2017 National
This submission responds to an Options paper on reducing pressure on private health insurance premiums by addressing the growth of private patients in public hospitals. HCCA's feedback comes from consulting with consumers.Senate Inquiry into Out-of-Pocket Costs in Australian Healthcare
Published: 2014 National
This is a submission to the Australian Senate Inquiry into Out-of-Pocket Costs in Australian Healthcare. It emphasises the impact of growing out-of-pocket costs on people with chronic conditions, families with young children and marginalised groups.Consideration of Hepatitis treatments Sofosbuvir & Simeprevir
Published: 2014 National
HCCA supports the addition of Sofosbuvir and Simeprevir to the Australian Government’s Pharmaceutical Benefits Scheme (PBS). HCCA strongly advocates for the introduction of these treatments in Australia to ensure choice, opportunity and access to these medicines which present significant advantages over currently available treatment options.Independent Hospital Pricing Authority: Consultation Paper on the Pricing Framework for Australian Public Hospital Services 2017-18
Published: 2016 National
HCCA's Submission to the Independent Hospital Pricing Authority's Consultation Paper on the Pricing Framework for Australian Public Hospital Services 2017-18.Review of the National Registration and Accreditation Scheme for Health Professionals
Published: 2014 National
The six key objectives of NRAS all have impacts on consumers, particularly, protection of public safety, facilitation of high-quality education and training, promotion of access to health services, and the development of a flexible, responsive and sustainable health service.National Review of Pharmacy Remuneration & Regulation
Published: 2016 National
HCCA commends the Panel for the Review on its broad and inclusive stakeholder consultation strategy, which included public meetings in major cities, country towns and indigenous settlements around Australia. It is critical to gaining insight into consumer needs and values in order to shape future planning for medicines policy in…Senate Inquiry into the Medical Complaints Process in Australia
Published: 2016 National
HCCA is pleased to provide this submission to the Senate Inquiry into the Medical Complaints Process in Australia. Robust and accessible complaints processes are essential to the delivery of a high quality, safe, Australian health system that meets health consumers’ needs and is valued by us.